Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
89 hedge funds and large institutions have $914M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 28 reducing their positions, and 9 closing their positions.
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
9% more funds holding
Funds holding: 82 → 89 (+7)
4% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 28
9% less capital invested
Capital invested by funds: $1.01B → $914M (-$90.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
+$21.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.8M |
| 3 |
Renaissance Technologies
New York
|
+$1.94M |
| 4 |
BlackRock
New York
|
+$1.79M |
| 5 |
Morgan Stanley
New York
|
+$1.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$19.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.8M |
| 3 |
State Street
Boston,
Massachusetts
|
-$16.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.3M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$4.6M |
FMTX Hedge Fund Activity: Q3 2021 in Review
89 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q3 2021, worth a combined $914M — down 9% from $1.01B a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new FMTX positions and 9 closed out — a net gain of 7 holders — while 29 added to existing stakes and 28 trimmed.
The largest buyer was Logos Global Management, adding an estimated $21.3M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $19.3M sold.
- 89 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q3 2021, up from 82 in Q2 2021.
- Funds reported $914M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q3 2021, down 9% quarter-over-quarter.
- 16 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q3 2021 and 9 closed out, a net change of +7 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q3 2021 was Logos Global Management, an estimated $21.3M added.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q3 2021 was Janus Henderson Group, an estimated $19.3M sold.
Based on aggregated 13F filings for Q3 2021.